Earnings Outlook For X4 Pharmaceuticals
Portfolio Pulse from Benzinga Insights
X4 Pharmaceuticals (NASDAQ:XFOR) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.15. The company's stock price has historically been affected more by its guidance than its earnings performance. Last quarter, the company missed EPS by $0.17, which was followed by a 21.9% increase in the share price. Over the last 52-week period, shares are down 59.07%.
November 08, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
X4 Pharmaceuticals is expected to report an EPS of $-0.15 in its upcoming earnings report. The company's stock price has been more influenced by its guidance than its earnings performance. Last quarter, despite missing EPS estimates, the stock price increased by 21.9%. However, the stock is down 59.07% over the last 52 weeks.
The upcoming earnings report and the company's guidance will likely have a significant impact on X4 Pharmaceuticals' stock price. Despite missing EPS estimates last quarter, the stock price increased, indicating that investors may be more interested in the company's future prospects than its current earnings. However, the stock's overall downward trend over the past year may indicate investor skepticism about the company's long-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100